We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Top Buys

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.7M
2
IMVT icon
Immunovant
IMVT
+$15.7M
3
LL
LL Flooring Holdings, Inc.
LL
+$11.4M
4
ACET icon
Adicet Bio
ACET
+$10.9M
5
INVZ icon
Innoviz Technologies
INVZ
+$9.95M

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$131M
2
IMCR icon
Immunocore
IMCR
+$34.1M
3
FTAI icon
FTAI Aviation
FTAI
+$28.1M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$20.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFARW
426
DELISTED
Aura FAT Projects Acquisition Corp Warrant
AFARW
$7.5K ﹤0.01%
229,930
– –
NOVVR
427
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$7.27K ﹤0.01%
60,600
-39,500
-39% -$4.68K
CGC
428
CALL
Canopy Growth
CGC
$422M
$7.25K ﹤0.01%
+5,000
New +$154K
PINS icon
429
PUT
Pinterest
PINS
$13.4B
$7.25K ﹤0.01%
+50,000
New +$1.19M
BTMWW
430
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$7.1K ﹤0.01%
111,101
-15,800
-12% -$1.44K
MCACW
431
DELISTED
Monterey Capital Acquisition Corporation Warrants
MCACW
$7.06K ﹤0.01%
176,550
-23,850
-12% -$933
SBCWW
432
SBC Medical Group Warrants
SBCWW
$2.65M
$6.97K ﹤0.01%
126,561
-10,100
-7% -$469
FTAAW
433
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$6.85K ﹤0.01%
139,718
+100,000
+252% +$2.84K
EUCRW
434
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$6.8K ﹤0.01%
122,257
– –
BRD.WS
435
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$6.79K ﹤0.01%
84,901
+1,590
+2% +$102
MCAAW
436
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$6.75K ﹤0.01%
225,000
– –
MSDAW
437
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$6.61K ﹤0.01%
85,332
-4,668
-5% -$298
RMGCW
438
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$6.56K ﹤0.01%
218,830
+57,888
+36% +$1.81K
CCVI.WS
439
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$6.55K ﹤0.01%
109,236
-44,106
-29% -$1.91K
RFACW
440
DELISTED
RF Acquisition Corp. Warrants
RFACW
$6.54K ﹤0.01%
522,832
-21,600
-4% -$531
HCNEW
441
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$6.44K ﹤0.01%
40,149
+27,649
+221% +$3.65K
NVACW
442
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$6.43K ﹤0.01%
135,410
+48,910
+57% +$1.55K
DUETW
443
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$6.42K ﹤0.01%
428,001
-50,300
-11% -$1.54K
TWCBW
444
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$6.3K ﹤0.01%
35,000
-4,124
-11% -$608
AIMAW
445
DELISTED
Aimfinity Investment Corp I Warrant
AIMAW
$6.27K ﹤0.01%
+208,332
New +$9.04K
GLS.WS
446
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$6.25K ﹤0.01%
702,089
+439,110
+167% +$8.69K
VLD.WS
447
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$6.15K ﹤0.01%
+30,039
New +$14.2K
SLACW
448
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$6.13K ﹤0.01%
102,470
+67,382
+192% +$10.1K
IRAAW
449
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$6.08K ﹤0.01%
+79,967
New +$3.85K
CHEAW
450
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
$6.06K ﹤0.01%
100,766
-65,900
-40% -$5.37K
16 17
18
19 20

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.